Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Real-World Prevalence of Adverse Events After Initiating Sacubitril/Valsartan Compared With Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers in Systolic Heart Failure
PaperCitations, authors & open-access status
Real-World Prevalence of Adverse Events After Initiating Sacubitril/Valsartan Compared With Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers in Systolic Heart Failure is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 3 citations, 2019 year and closed oa status.
3
Citations
2019
Year
closed
OA Status